A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

October 9, 2025

Primary Completion Date

October 13, 2027

Study Completion Date

July 22, 2032

Conditions
Geographic Atrophy
Interventions
DRUG

SAR446597

Intravitreal injection

DRUG

Sham Comparator

Sham periocular injection

Trial Locations (2)

85381

RECRUITING

Associated Retina Consultants - Peoria - DocTrials - PPDS- Site Number : 8400011, Peoria

32607-2557

RECRUITING

Vitreo Retinal Associates, P.A.- Site Number : 8400004, Gainesville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT07215234 - A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration | Biotech Hunter | Biotech Hunter